MediciNova Initiates Sheep Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

June 7, 2021
10:30 am

MediciNova Initiates Sheep Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

LA JOLLA, Calif., June 07, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has initiated a…

Click here to view the original article.

featured, Global, Yahoo Entertainment

Share this article

Morgan Stanley Applies for Charter to Custody Crypto

March 2, 2026

Crypto news: Bitcoin gains almost 2% despite the war in the Middle East 📈

March 2, 2026

Crypto Startup Zap Africa Reduces Staff by 44% as It Shifts to AI Tools

March 2, 2026

Riot, Core earnings, U.S. jobs report: Crypto Week Ahead

March 2, 2026

Hong Kong moves to license stablecoin issuers and regulate crypto dealers.

March 2, 2026

Cardano Founder Says Crypto Market’s Best Days Are Still Ahead

March 2, 2026

CLARITY Act mid-year OK sparks H2 crypto rebound

March 2, 2026

TRXUSD TRON USD Slides 1.11% Daily—Can It Hold $0.27 Support?

March 2, 2026